Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Hua Dong

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Frontiers in Cardiovascular Medicine|September 24, 2021
Expression and Functional Analysis of lncRNAs Involved in Platelet-Derived Growth Factor-BB-Induced Proliferation of Human Aortic Smooth Muscle CellsJia-Jie Lin, Wei Chen, Miao Gong, et al.
Journal of Molecular and Cellular Cardiology|May 5, 2015
SM22α inhibits vascular inflammation via stabilization of IκBα in vascular smooth muscle cellsYa-Nan Shu, Fan Zhang, Wei Bi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 12, 2017
Accumulation of Smooth Muscle 22α Protein Accelerates Senescence of Vascular Smooth Muscle Cells via Stabilization of p53 In Vitro and In VivoSui-Bing Miao, Xiao-Li Xie, Ya-Juan Yin, et al.
Genome Medicine|May 1, 2020
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trialMing-Ci Cai, Shu Cheng, Xin Wang, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 16, 2016
Insulin-independent GLUT4 translocation in proliferative vascular smooth muscle cells involves SM22αLi-Li Zhao, Fan Zhang, Peng Chen, et al.
Cardiovascular Research|April 19, 2017
CKII-SIRT1-SM22α loop evokes a self-limited inflammatory response in vascular smooth muscle cellsYa-Nan Shu, Li-Hua Dong, Han Li, et al.
Practical Radiation Oncology|September 4, 2022
Variability of Target Volumes and Organs at Risk Delineation in Breast Cancer Radiation Therapy: Quality Assurance Results of the Pretrial Benchmark Case for the POTENTIAL TrialYu-Chun Song, Xue-Na Yan, Yu Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2023
Dose-Volume Predictors for Radiation Esophagitis in Patients With Breast Cancer Undergoing Hypofractionated Regional Nodal Radiation TherapyDan-Qiong Wang, Na Zhang, Li-Hua Dong, et al.
Radiation Oncology (London, England)|November 29, 2023
Quality assurance in a phase III, multicenter, randomized trial of POstmastectomy radioThErapy in Node posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a planning benchmark caseYu-Chun Song, Zhi-Hui Hu, Xue-Na Yan, et al.
Molecular Biomedicine|December 9, 2025
Clinicopathological characteristics, genetic aberrations, and optimized treatment strategies in double-hit and triple-hit lymphoma: a multi-center cohort studyYi-Ge Shen, Meng-Meng Ji, Qing Shi, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Frontiers in Cardiovascular Medicine|September 24, 2021
Expression and Functional Analysis of lncRNAs Involved in Platelet-Derived Growth Factor-BB-Induced Proliferation of Human Aortic Smooth Muscle CellsJia-Jie Lin, Wei Chen, Miao Gong, et al.
Journal of Molecular and Cellular Cardiology|May 5, 2015
SM22α inhibits vascular inflammation via stabilization of IκBα in vascular smooth muscle cellsYa-Nan Shu, Fan Zhang, Wei Bi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 12, 2017
Accumulation of Smooth Muscle 22α Protein Accelerates Senescence of Vascular Smooth Muscle Cells via Stabilization of p53 In Vitro and In VivoSui-Bing Miao, Xiao-Li Xie, Ya-Juan Yin, et al.
Genome Medicine|May 1, 2020
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trialMing-Ci Cai, Shu Cheng, Xin Wang, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 16, 2016
Insulin-independent GLUT4 translocation in proliferative vascular smooth muscle cells involves SM22αLi-Li Zhao, Fan Zhang, Peng Chen, et al.
Cardiovascular Research|April 19, 2017
CKII-SIRT1-SM22α loop evokes a self-limited inflammatory response in vascular smooth muscle cellsYa-Nan Shu, Li-Hua Dong, Han Li, et al.
Practical Radiation Oncology|September 4, 2022
Variability of Target Volumes and Organs at Risk Delineation in Breast Cancer Radiation Therapy: Quality Assurance Results of the Pretrial Benchmark Case for the POTENTIAL TrialYu-Chun Song, Xue-Na Yan, Yu Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2023
Dose-Volume Predictors for Radiation Esophagitis in Patients With Breast Cancer Undergoing Hypofractionated Regional Nodal Radiation TherapyDan-Qiong Wang, Na Zhang, Li-Hua Dong, et al.
Radiation Oncology (London, England)|November 29, 2023
Quality assurance in a phase III, multicenter, randomized trial of POstmastectomy radioThErapy in Node posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a planning benchmark caseYu-Chun Song, Zhi-Hui Hu, Xue-Na Yan, et al.
Molecular Biomedicine|December 9, 2025
Clinicopathological characteristics, genetic aberrations, and optimized treatment strategies in double-hit and triple-hit lymphoma: a multi-center cohort studyYi-Ge Shen, Meng-Meng Ji, Qing Shi, et al.
Pageof 9